AMPA receptor antagonists
- 1 May 1999
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 9 (5) , 557-570
- https://doi.org/10.1517/13543776.9.5.557
Abstract
It is now generally recognised that glutamate is the major excitatory neurotransmitter in vertebrate central nervous system (CNS). It acts at ionotropic and metabotropic receptors which appear to play important roles in all aspects of CNS functions. The ionotropic receptors, which are involved in fast synaptic transmission, belong to three subtypes named after three relatively selective agonists: NMDA (N-methyl-D-aspartate, AMPA [2- amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)-propionate] and KA (kainate) receptors. The compounds acting as AMPA antagonists are potentially useful for the prevention and treatment of a broad range of acute and chronic neurological disorders. This article describes the development of recent AMPA receptor antagonists, reviewing both the primary and patent literature.Keywords
This publication has 41 references indexed in Scilit:
- Design of excitatory amino acid receptor agonists, partial agonists and antagonists: ibotenic acid as a key lead structureEuropean Journal of Medicinal Chemistry, 1996
- Therapeutic Potential of AMPA Receptor Ligands in Neurological DisordersCNS Drugs, 1996
- Synthesis and Pharmacology of Highly Selective Carboxy and Phosphono Isoxazole Amino Acid AMPA Receptor AntagonistsJournal of Medicinal Chemistry, 1996
- A Molecular Determinant for Submillisecond Desensitization in Glutamate ReceptorsScience, 1994
- Molecular pharmacology of the AMPA agonist, (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(S)-APPA] and the AMPA antagonist, (R)-APPANeurochemistry International, 1994
- Resolution, Absolute Stereochemistry, and Pharmacology of the S-(+)- and R-(-)-Isomers of the Apparent Partial AMPA Receptor Agonist (R,S)-2-Amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic Acid [(R,S)-APPA]Journal of Medicinal Chemistry, 1994
- Cloned Glutamate ReceptorsAnnual Review of Neuroscience, 1994
- Novel Glutamate Receptor Antagonists Selectively Protect Against Kainic Acid Neurotoxicity in Cultured Cerebral Cortex NeuronsJournal of Neurochemistry, 1990
- 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral IschemiaScience, 1990
- Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor AntagonistsScience, 1988